Literature DB >> 18189241

Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels.

Elizabeth M Tunbridge1, Paul J Harrison, Donald R Warden, Carole Johnston, Helga Refsum, A David Smith.   

Abstract

Elevated plasma total homocysteine (tHcy) is a risk factor for various disorders. We investigated whether functional polymorphisms in catechol-O-methyltransferase (COMT) influence tHcy, since COMT activity produces S-adenosylhomocysteine (SAH), a homocysteine precursor. We hypothesized that high activity COMT variants would be associated with high tHcy, since they presumably result in increased formation of SAH. We genotyped 780 community-dwelling elderly individuals for functional COMT (Val(158)Met and A(-287)G) and methylenetetrahydrofolate reductase (MTHFR; C(677)T) polymorphisms, and measured plasma tHcy. As predicted, COMT Val(158) carriers had significantly higher tHcy than Met(158) homozygotes. The effect was limited to individuals homozygous for the MTHFR T(677) allele. In addition, individuals homozygous for the COMT G(-287) allele tended to have lower tHcy levels. High activity variants of COMT interact with the low activity variant of MTHFR to increase tHcy levels. The effect on tHcy may contribute to the reported associations of COMT genotype with psychiatric and neurobiological phenotypes. The results also indicate that COMT activity may influence a broader range of biochemical pathways than hitherto appreciated. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18189241     DOI: 10.1002/ajmg.b.30700

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  20 in total

1.  Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics.

Authors:  Vicki L Ellingrod; Stephan F Taylor; Gregory Dalack; Tyler B Grove; Michael J Bly; Robert D Brook; Sebastian K Zöllner; Rodica Pop-Busui
Journal:  J Clin Psychopharmacol       Date:  2012-04       Impact factor: 3.153

2.  Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders.

Authors:  Tyler Grove; Stephan Taylor; Gregory Dalack; Vicki Ellingrod
Journal:  Schizophr Res       Date:  2015-02-23       Impact factor: 4.939

3.  COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV.

Authors:  Rowan Saloner; Maria J Marquine; Erin E Sundermann; Suzi Hong; John Allen McCutchan; Ronald J Ellis; Robert K Heaton; Igor Grant; Mariana Cherner
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-15       Impact factor: 3.731

Review 4.  Germline genetic variants with implications for disease risk and therapeutic outcomes.

Authors:  Amy L Pasternak; Kristen M Ward; Jasmine A Luzum; Vicki L Ellingrod; Daniel L Hertz
Journal:  Physiol Genomics       Date:  2017-09-08       Impact factor: 3.107

5.  The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia.

Authors:  S A Lott; P R Burghardt; K J Burghardt; M J Bly; T B Grove; V L Ellingrod
Journal:  Pharmacogenomics J       Date:  2012-03-06       Impact factor: 3.550

6.  Association analysis of the COMT/MTHFR genes and geriatric depression: an MRI study of the putamen.

Authors:  Chih-Chuan Pan; Douglas R McQuoid; Warren D Taylor; Martha E Payne; Allison Ashley-Koch; David C Steffens
Journal:  Int J Geriatr Psychiatry       Date:  2009-08       Impact factor: 3.485

7.  MTHFR 677C --> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val --> Met.

Authors:  Joshua L Roffman; Randy L Gollub; Vince D Calhoun; Thomas H Wassink; Anthony P Weiss; Beng C Ho; Tonya White; Vincent P Clark; Jill Fries; Nancy C Andreasen; Donald C Goff; Dara S Manoach
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

8.  Epistatic and functional interactions of catechol-o-methyltransferase (COMT) and AKT1 on neuregulin1-ErbB signaling in cell models.

Authors:  Yoshitatsu Sei; Zhen Li; Jian Song; Renee Ren-Patterson; Elizabeth M Tunbridge; Yukihiko Iizuka; Masahiro Inoue; Berenice T Alfonso; Senda Beltaifa; Yoko Nakai; Bhaskar S Kolachana; Jingshan Chen; Daniel R Weinberger
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

9.  Variants in maternal COMT and MTHFR genes and risk of neural tube defects in offspring.

Authors:  Jufen Liu; Yali Zhang; Lei Jin; Guoxing Li; Linlin Wang; Yanping Bao; Yunting Fu; Zhiwen Li; Le Zhang; Rongwei Ye; Aiguo Ren
Journal:  Metab Brain Dis       Date:  2014-07-04       Impact factor: 3.584

Review 10.  Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy : is there a role for folate?

Authors:  Kyle J Burghardt; Vicki L Ellingrod
Journal:  Mol Diagn Ther       Date:  2013-02       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.